DOW Stock Analysis: Dow | NYSE
Chemicals | NYSE, USA | Market Cap: 19.893m USD | 12M Return: 23.9% | US2605571031 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 261M
Qual. Beats: 3
Rev. Trend: -92.4%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 7.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Dow Inc. (NYSE: DOW) is a United States-based materials science company that provides chemistry-based solutions for packaging, infrastructure, mobility, and consumer applications across global markets including North America, Europe, the Middle East, Africa, India, Asia Pacific, and Latin America. The company operates through three core segments: Packaging & Specialty Plastics (producing ethylene, propylene, polyethylene, aromatics, and related derivatives), Industrial Intermediates & Infrastructure (polyurethanes, chlor-alkali and vinyl products, and construction chemicals), and Performance Materials & Coatings (architectural and industrial coatings, acrylics, silicon metals, and siloxanes). In addition to its chemicals operations, Dow maintains a property and casualty insurance and reinsurance business. The company was founded in 1897 and is headquartered in Midland, Michigan.
Factual context: Dow is classified within the GICS Materials sector and Commodity Chemicals sub-industry, and is a large-cap stock. The company was spun off and began trading as a standalone public entity in March 2019 following the breakup of DowDuPont, separating its commodity chemicals business from the former merged entitys specialty operations.
- Polyethylene oversupply pressures Packaging & Specialty Plastics margins
- Natural gas feedstock advantage supports Gulf Coast ethylene production
- Dividend payout strains cash flow amid cyclical earnings weakness
| Net Income: -1.21b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -0.66 > 1.0 |
| NWC/Revenue: 25.01% < 20% (prev 17.28%; Δ 7.73% < -1%) |
| CFO/TA 0.07 > 3% & CFO 4.61b > Net Income -1.21b |
| Net Debt (19.4b) to EBITDA (2.30b): 8.44 < 3 |
| Current Ratio: 1.98 > 1.5 & < 3 |
| Outstanding Shares: last quarter (709.5m) vs 12m ago 0.60% < -2% |
| Gross Margin: 9.79% > 18% (prev 7.41%; Δ 2.37% > 0.5%) |
| Asset Turnover: 68.54% > 50% (prev 70.89%; Δ -2.35% > 0%) |
| Interest Coverage Ratio: 0.22 > 6 (EBIT TTM 192.0m / Interest Expense TTM 869.0m) |
| A: 0.17 (Total Current Assets 20.9b - Total Current Liabilities 10.5b) / Total Assets 61.6b |
| B: 0.27 (Retained Earnings 16.5b / Total Assets 61.6b) |
| C: 0.00 (EBIT TTM 192.0m / Avg Total Assets 60.3b) |
| D: 0.69 (Book Value of Equity 24.4b / Total Liabilities 35.6b) |
| Altman-Z'' = 2.71 = A |
| DSRI: 1.12 (Receivables 8.48b/7.65b, Revenue 41.3b/41.8b) |
| GMI: 0.76 (GM 7.41% / 9.79%) |
| AQI: 0.94 (AQ_t 0.28 / AQ_t-1 0.30) |
| SGI: 0.99 (Revenue 41.3b / 41.8b) |
| TATA: -0.09 (NI -1.21b - CFO 4.61b) / TA 61.6b) |
| Beneish M = -3.20 (Cap -4..+1) = AA |
As of October 05, 2026, the stock is trading at USD 27.97 with a total of 7,340,562 shares traded. Over the past week, the price has changed by -0.18%, over one month by -10.58%, over three months by +2.11% and over the past year by +23.89%.
Current recommended Stop Loss: 26.80 (which is 4.2% or 1.3 ATR below the current price).
Dow has received a consensus analysts rating of 3.33. Therefore, it is recommended to hold DOW.
- StrongBuy: 4
- Buy: 0
- Hold: 16
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 33.8 | 20.9% |
P/E Forward = 14.1443
P/S = 0.4815
P/B = 1.3049
P/EG = 38.8911
Revenue TTM = 41.3b USD
EBIT TTM = 192.0m USD
EBITDA TTM = 2.30b USD
Long Term Debt = 16.1b USD (from longTermDebt, last quarter)
Short Term Debt = 1.53b USD (from shortTermDebt, last quarter)
Debt = 23.4b USD (from shortLongTermDebtTotal, last quarter) + Leases 2.50b
Net Debt = 19.4b USD (calculated: Debt 23.4b - CCE 3.97b)
Enterprise Value = 39.3b USD (19.9b + Debt 23.4b - CCE 3.97b)
Interest Coverage Ratio = 0.22 (Ebit TTM 192.0m / Interest Expense TTM 869.0m)
EV/FCF = -28.49x (Enterprise Value 39.3b / FCF TTM -1.38b)
FCF Yield = -3.51% (FCF TTM -1.38b / Enterprise Value 39.3b)
FCF Margin = -3.34% (FCF TTM -1.38b / Revenue TTM 41.3b)
Net Margin = -2.92% (Net Income TTM -1.21b / Revenue TTM 41.3b)
Gross Margin = 9.79% ((Revenue TTM 41.3b - Cost of Revenue TTM 37.3b) / Revenue TTM)
Gross Margin QoQ = 17.92% (prev 6.53%)
Tobins Q-Ratio = 0.64 (Enterprise Value 39.3b / Total Assets 61.6b)
Interest Expense / Debt = 3.72% (Interest Expense 869.0m / Debt 23.4b)
Taxrate = 7.92% (69.0m / 871.0m)
NOPAT = 176.8m (EBIT 192.0m * (1 - 7.92%))
Current Ratio = 1.31 (Total Current Assets 20.9b / Total Current Liabilities 15.9b)
Debt / Equity = 0.96 (Debt 23.4b / totalStockholderEquity, last quarter 24.4b)
Debt / EBITDA = 8.44 (Net Debt 19.4b / EBITDA 2.30b)
Debt / FCF = -14.06 (negative FCF - burning cash) (Net Debt 19.4b / FCF TTM -1.38b)
Total Stockholder Equity = 18.3b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.00% (Net Income -1.21b / Total Assets 61.6b)
RoE = -6.58% (Net Income TTM -1.21b / Total Stockholder Equity 18.3b)
RoCE = 0.56% (EBIT 192.0m / Capital Employed (Equity 18.3b + L.T.Debt 16.1b))
RoIC = 0.30% (NOPAT 176.8m / Invested Capital 59.2b)
WACC = 5.71% (E(19.9b)/V(43.3b) * Re(8.40%) + D(23.4b)/V(43.3b) * Rd(3.72%) * (1-Tc(0.08)))
Discount Rate = 8.40% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 72.72 | Cagr: 0.25%
[DCF] Fair Price = unknown (Cash Flow -1.38b)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 1.06 | # QB: 3
Revenue Correlation: -92.36 | Revenue CAGR: -4.43% | SUE: 0.38 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.66 | Chg30d=-14.39% | Revisions=-40% | Analysts=15
EPS current Year (2026-12-31): EPS=2.42 | Chg30d=-2.08% | Revisions=-40% | GrowthEPS=+356.9% | GrowthRev=+9.2%
EPS next Year (2027-12-31): EPS=1.72 | Chg30d=-6.49% | Revisions=-17% | GrowthEPS=-28.9% | GrowthRev=-2.0%
[Analyst] Revisions Ratio: -45% (up=4, down=13)